Found: 103
Select item for more details and to access through your institution.
The costimulatory molecule CD70 is regulated by distinct molecular mechanisms and is associated with overall survival in diffuse large B-cell lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2013, v. 52, n. 8, p. 764, doi. 10.1002/gcc.22072
- By:
- Publication type:
- Article
Neurological toxicity related to pefloxacin.
- Published in:
- 1988
- By:
- Publication type:
- case study
Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases.
- Published in:
- British Journal of Dermatology, 1995, v. 132, n. 4, p. 506
- By:
- Publication type:
- Article
Immunological evaluation of harvested stem cells obtained by leukapheresis after chemotherapy.
- Published in:
- American Journal of Hematology, 1992, v. 39, n. 3, p. 172, doi. 10.1002/ajh.2830390304
- By:
- Publication type:
- Article
Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histology.
- Published in:
- Oncogene, 2006, v. 25, n. 35, p. 4947, doi. 10.1038/sj.onc.1209512
- By:
- Publication type:
- Article
Change in energy and protein status during chemotherapy in patients with acute leukemia.
- Published in:
- 1988
- By:
- Publication type:
- journal article
Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 1, p. 252, doi. 10.1038/leu.2012.172
- By:
- Publication type:
- Article
High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis.
- Published in:
- 2012
- By:
- Publication type:
- Letter
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 4, p. 681, doi. 10.1038/leu.2010.302
- By:
- Publication type:
- Article
Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Peripheral blood stem cells collected before and after leukapheresis in the very early remission phase of hematopoietic malignancies.
- Published in:
- European Journal of Haematology, 1989, v. 42, n. 5, p. 481, doi. 10.1111/j.1600-0609.1989.tb01474.x
- By:
- Publication type:
- Article
Human herpesvirus-6 acute limbic encephalitis after unrelated umbilical cord blood transplantation successfully treated with ganciclovir.
- Published in:
- Bone Marrow Transplantation, 2015, v. 50, n. 10, p. 1385, doi. 10.1038/bmt.2015.159
- By:
- Publication type:
- Article
The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.
- Published in:
- Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1409, doi. 10.1038/bmt.2013.83
- By:
- Publication type:
- Article
Current status and future perspectives for yttrium-90 (<sup>90</sup>Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma.
- Published in:
- Bone Marrow Transplantation, 2007, v. 40, n. 11, p. 1007, doi. 10.1038/sj.bmt.1705868
- By:
- Publication type:
- Article
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 4, p. 698, doi. 10.1038/leu.2008.359
- By:
- Publication type:
- Article
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease.
- Published in:
- 2009
- By:
- Publication type:
- Correction notice
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Characterization of three t(3;8)(q27;q24) translocations from diffuse large B-cell lymphomas.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 11, p. 2324, doi. 10.1038/sj.leu.2404850
- By:
- Publication type:
- Article
Conventional cytogenetics of nodular lymphocyte-predominant Hodgkin's lymphoma.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Comparison of a quantitative PCR method with FISH for the assessment of the four aneuploidies commonly evaluated in CLL patients.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 7, p. 1460, doi. 10.1038/sj.leu.2404727
- By:
- Publication type:
- Article
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Novel Ig V gene features of t(14;18) and t(3;14) de novo diffuse large B-cell lymphoma displaying germinal center-B cell like and non-germinal center-B cell like markers.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 11, p. 2070, doi. 10.1038/sj.leu.2404370
- By:
- Publication type:
- Article
Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 10, p. 1824, doi. 10.1038/sj.leu.2403915
- By:
- Publication type:
- Article
Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
- Published in:
- Leukemia (08876924), 2004, v. 18, n. 11, p. 1924, doi. 10.1038/sj.leu.2403440
- By:
- Publication type:
- Article
Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
- Published in:
- Leukemia (08876924), 2002, v. 16, n. 11, p. 2318, doi. 10.1038/sj.leu.2402657
- By:
- Publication type:
- Article
Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
- Published in:
- Leukemia (08876924), 2002, v. 16, n. 11, p. 2309, doi. 10.1038/sj.leu.2402707
- By:
- Publication type:
- Article
Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?
- Published in:
- Leukemia (08876924), 2002, v. 16, n. 9, p. 1852, doi. 10.1038/sj.leu.2402568
- By:
- Publication type:
- Article
De novo acute B cell leukemia/lymphoma with t(14;18).
- Published in:
- 2000
- By:
- Publication type:
- journal article
Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3' BCL2 breakpoints and evidence of a new cluster.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial).
- Published in:
- 1999
- By:
- Publication type:
- journal article
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden: a multicenter phase 2 trial by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) and Groupe Ouest Est des Leucémies et Autres Maladies du Sang (GOELAMS)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Autoimmune Phenomena Associated with Cutaneous Aseptic Necrosis During Interferon-alpha Treatment for Chronic Myelogeous Leukaemia.
- Published in:
- British Journal of Rheumatology, 1995, v. 34, n. 6, p. 582
- By:
- Publication type:
- Article
Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 680, doi. 10.1007/s00259-017-3907-x
- By:
- Publication type:
- Article
Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia.
- Published in:
- Bone Marrow Transplantation, 2005, v. 35, n. 8, p. 767, doi. 10.1038/sj.bmt.1704884
- By:
- Publication type:
- Article
Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age.
- Published in:
- Bone Marrow Transplantation, 1997, v. 19, n. 1, p. 31, doi. 10.1038/sj.bmt.1700604
- By:
- Publication type:
- Article
RADIOMICS REFLECTING BOTH TUMOR AND HOST FEATURES IMPROVES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 94, doi. 10.1002/hon.3163_58
- By:
- Publication type:
- Article
RISK STRATIFICATION OF DLBCL WITH MVED2 SCORE USING INTEGRATIVE HOST ADIPOSE DENSITY AND METABOLIC TUMOR CHARACTERISTICS COMPARED TO OTHER INDEXES.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 91, doi. 10.1002/hon.3163_55
- By:
- Publication type:
- Article
COMBINING BASELINE TOTAL METABOLIC TUMOR VOLUME AND BETA‐2‐MICROGLOBULIN LEVELS PREDICTS OUTCOMES IN HIGH BURDEN FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 670, doi. 10.1002/hon.3165_518
- By:
- Publication type:
- Article
Combination of pixantrone with rituximab, ifosfamide and etoposide in relapsed/refractory aggressive non‐Hodgkin lymphoma. Results from a phase II LYSA study (PIVeR).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 437, doi. 10.1002/hon.3164_322
- By:
- Publication type:
- Article
Pola‐R‐CHP versus R‐CHOEP in young patients with high‐risk diffuse large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 420, doi. 10.1002/hon.3164_308
- By:
- Publication type:
- Article
Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 416, doi. 10.1002/hon.3164_306
- By:
- Publication type:
- Article
Patient‐ versus clinician‐reported symptoms in the POLARIX study.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 414, doi. 10.1002/hon.3164_305
- By:
- Publication type:
- Article
CIRCULATING TUMOR DNA (CTDNA) STATUS AND CLINICAL OUTCOMES IN PATIENTS (PTS) WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE POLARIX STUDY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 175, doi. 10.1002/hon.3163_111
- By:
- Publication type:
- Article
LONG‐TERM OUTCOMES OF ELDERLY PATIENTS TREATED WITH FRONTLINE R‐CHOP: UPDATE OF THE LNH03‐6B TRIAL.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.96_2880
- By:
- Publication type:
- Article
SELINEXOR IN COMBINATION WITH R‐GDP FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE SELINDA PHASE IB LYSA STUDY (EUDRACT NUMBER: 2015‐005612‐15)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.88_2880
- By:
- Publication type:
- Article
SELINEXOR IN COMBINATION WITH R‐GDP FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMA: PRELIMINARY RESULTS OF THE SELINDA PHASE IB LYSA STUDY (EUDRACT NUMBER: 2015‐005612‐15)
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.87_2880
- By:
- Publication type:
- Article
HIGH ADIPOSE TISSUE DENSITY IS A NEGATIVE PROGNOSTIC FACTOR IN DLBCL PATIENTS TREATED BY R‐CHOP, INDEPENDENT FROM TMTV AND PS –FROM THE REMARC STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.78_2880
- By:
- Publication type:
- Article